Legend BiotechCorp Market Capitalization vs. Book Value Per Share
| LEGN Stock | USD 51.71 1.21 2.29% |
Legend BiotechCorp Market Cap |
|
For Legend BiotechCorp profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Legend BiotechCorp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Legend BiotechCorp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Legend BiotechCorp's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Legend BiotechCorp over time as well as its relative position and ranking within its peers.
Legend |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 1.619 | Quarterly Revenue Growth 1.876 | Return On Assets (0.17) | Return On Equity (0.52) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Legend BiotechCorp Book Value Per Share vs. Market Capitalization Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Legend BiotechCorp's current stock value. Our valuation model uses many indicators to compare Legend BiotechCorp value to that of its competitors to determine the firm's financial worth. Legend BiotechCorp is rated fourth overall in market capitalization category among related companies. It is rated below average in book value per share category among related companies . The ratio of Market Capitalization to Book Value Per Share for Legend BiotechCorp is about 1,399,437,490 . At this time, Legend BiotechCorp's Market Cap is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Legend BiotechCorp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Legend BiotechCorp's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Legend BiotechCorp's earnings, one of the primary drivers of an investment's value.Legend Market Capitalization vs. Competition
Legend BiotechCorp is rated fourth overall in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 135.77 Billion. Legend BiotechCorp holds roughly 9.63 Billion in market capitalization claiming about 7% of equities under Health Care industry.
Legend Book Value Per Share vs. Market Capitalization
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Legend BiotechCorp |
| = | 9.63 B |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Legend BiotechCorp |
| = | 6.88 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Legend Book Value Per Share Comparison
Legend BiotechCorp is currently under evaluation in book value per share category among related companies.
Legend BiotechCorp Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Legend BiotechCorp, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Legend BiotechCorp will eventually generate negative long term returns. The profitability progress is the general direction of Legend BiotechCorp's change in net profit over the period of time. It can combine multiple indicators of Legend BiotechCorp, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 98.9 M | 94 M | |
| Operating Income | -442.2 M | -420.1 M | |
| Income Before Tax | -520.1 M | -494.1 M | |
| Net Loss | -401.7 M | -381.6 M | |
| Net Loss | -518.3 M | -492.3 M | |
| Income Tax Expense | -1.9 M | -1.8 M | |
| Net Interest Income | 21.2 M | 22.3 M | |
| Interest Income | 42.1 M | 44.2 M | |
| Net Loss | -509.3 M | -483.8 M | |
| Total Other Income Expense Net | -77.9 M | -74 M | |
| Change To Netincome | 39.3 M | 55.1 M | |
| Net Loss | (2.94) | (3.09) | |
| Income Quality | 0.74 | 0.78 | |
| Net Income Per E B T | 1.00 | 1.23 |
Legend Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Legend BiotechCorp. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Legend BiotechCorp position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Legend BiotechCorp's important profitability drivers and their relationship over time.
Use Legend BiotechCorp in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Legend BiotechCorp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend BiotechCorp will appreciate offsetting losses from the drop in the long position's value.Legend BiotechCorp Pair Trading
Legend BiotechCorp Pair Trading Analysis
The ability to find closely correlated positions to Legend BiotechCorp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Legend BiotechCorp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Legend BiotechCorp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Legend BiotechCorp to buy it.
The correlation of Legend BiotechCorp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Legend BiotechCorp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Legend BiotechCorp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Legend BiotechCorp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Legend BiotechCorp position
In addition to having Legend BiotechCorp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Energy Funds Thematic Idea Now
Energy Funds
Funds or Etfs investing in energy sector, natural resources, and ecology. The Energy Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
To fully project Legend BiotechCorp's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Legend BiotechCorp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Legend BiotechCorp's income statement, its balance sheet, and the statement of cash flows.